Luis Murguía-Favela

My practice and research interests are mainly focused in primary immune deficiencies and immune dysregulation disorders. I am the site co-investigator for the PIDTC (Primary Immune Deficiency Treatment Consortium) which consists of 42 centers in North America whose shared goal is to improve the outcome of patients with rare, life threatening, inherited disorders of the immune system. I am also a founding member and site principal investigator of the Clinical Immunology Network-Canada (CINC), a cross-Canada group of Clinical Immunologists with the objective of generating and collaborating on clinical research and advocacy projects in the field of Immunology.